Medical University of Vienna
Vienna, State of Vienna, 1090, Austria
NCT Number: NCT07479511
This prospective observational study investigates the effects of intermittent hypoxic conditioning and real high-altitude exposure in lung transplant recipients compared with healthy controls.
The study includes an eight-week home-based preparatory phase during which participants use a normobaric hypoxic tent with reduced oxygen concentration. Prior to this phase, all participants receive standardized training on the safe use of the equipment. During the preparatory period, daily vital parameters, including heart rate, oxygen saturation, and heart rate variability, are recorded using a sports watch and a pulse oximeter. Symptoms, adverse events, and subjective well-being are documented daily in an electronic diary. All data are transmitted to the study team via encrypted electronic systems, allowing continuous remote monitoring. At the end of the preparatory phase, participants undergo a clinical evaluation to confirm fitness for the expedition phase.
The expedition phase consists of a monitored ascent of Aconcagua (6,971 meters). Before departure, all participants are required to attend a comprehensive safety, protection, and first aid training conducted jointly by the study team and professional expedition providers. The expedition is planned and led by an experienced international expedition company in cooperation with a local provider specializing in high-altitude mountaineering.
The expedition includes arrival in Mendoza, preparatory procedures such as equipment checks and permits, followed by a staged ascent to base camp. Subsequent days involve rest periods and acclimatization hikes with the establishment of progressively higher camps. A summit attempt is planned after sufficient acclimatization, followed by descent to high camp. A weather-dependent buffer period is included before the final descent to the valley and return to Mendoza, where the expedition concludes.
Total study participation is expected to last approximately 15 weeks, including about eight weeks of home-based preparation and approximately three weeks at altitude. A final follow-up examination is conducted 2 to 4 weeks after completion of the expedition, marking the end of study participation.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Vienna, State of Vienna, 1090, Austria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Lung transplant recipients:
Healthy volunteers:
Exclusion criteria
Lung transplant recipients:
Healthy controls:
Time frame: From enrollment to the end of the expedition at 3 weeks
Time frame: From enrollment to the end of the expedition at 3 weeks
Time frame: From enrollment to the end of the expedition at 3 weeks
Time frame: From enrollment to the end of the expedition at 3 weeks
Time frame: From enrollment to the end of the expedition at 3 weeks
Time frame: From enrollment to the end of the expedition at 3 weeks
Time frame: Before enrollment until approx. 4 weeks after the end of the expedition
Time frame: Prior to enrollment to the end of the expedition at 3 weeks
Voice-based heart failure detection developed by Noah Labs uses artificial intelligence to analyze short voice recordings from patients with heart failure. Patients regularly record a standardized speech sample using a smartphone. Deep-learning algorithms extract numerous acoustic features such as frequency patterns and subtle variations in vocal cord vibration. The system identifies these changes as "voice biomarkers" and compares them with previous recordings. If patterns suggest worsening heart failure, clinicians can be alerted early, potentially allowing timely therapeutic adjustments and preventing hospitalizations. The study aims to investigate changes in height and in patients following lung transplantation.
Time frame: Prior to enrollment to the end of the expedition at 3 weeks
The composition of the gut microbiota is being studied longitudinally using stool samples collected prior to the expedition and following successive ascents to high altitudes over the course of several weeks. The samples are analyzed to determine bacterial diversity and taxonomic composition. Microbial diversity indices, including Shannon, Simpson, and Chao1, are calculated to assess changes in community structure. In addition, the Bray-Curtis distance and the Jaccard index are used to assess differences in species distribution across time points. The relative abundance of bacterial taxa is quantified to identify shifts in pathogenic and beneficial microbial populations during altitude exposure.
Time frame: Prior to enrollment to the end of the expedition at 3 weeks
Time frame: Prior to enrollment to the end of the expedition at 3 weeks
Time frame: Prior to enrollment to the end of the expedition at 3 weeks
Time frame: Prior to enrollment to the end of the expedition at 3 weeks
Time frame: Prior to enrollment to the end of the expedition at 3 weeks
Medical University of Vienna
Other
Assessment of Pulmonary Function and Physiological Adaptation of Lung Transplant Recipients at Extreme Altitude: The Mount Aconcagua (6971 m) Expedition
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00457847
Cardiovascular Diseases, Lung Transplantation
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07356752
Behavior, Chronic Lung Allograft Dysfunction (CLAD)
Paris, Paris 14, France
View Trial DetailsNCT07316829
Antibodies, Donor-Specific, Antibody-mediated Rejection
Pavia, Italy
View Trial DetailsNCT05309551
Chronic Lung Disease, Lung Transplantation
Columbus, Ohio, United States
View Trial Details